miR-22-3p/PGC1β Suppresses Breast Cancer Cell Tumorigenesis via PPARγ

Table 1

The relationship between the expression of miR-22-3p and various clinicopathological variables.

Patients characteristics	Total	miR-22-3p expression		value
		High ()	Low ()
Age				0.7065
<60	20	5	15
≥60	27	7	20
TNM stage				0.0200
I and II	30	11	19
III and IV	17	1	16
Tumor size (cm)				0.0237
≤2	26	10	16
>2	21	2	19
Lymph node metastasis				0.0423
Negative	32	11	21
Positive	15	1	14
Distant metastasis				0.0931
No	40	12	28
Yes	7	0	7

value from a chi-square test ().